Galilee Medical Center, abbreviated GMC, is a hospital located in the coastal city of Nahariya and is the second largest hospital in northern Israel. It was established in 1956.

There are 722 beds in Galilee Medical Center Department of Internal Medicine A.

During the past decade, Galilee Medical Center Department of Internal Medicine A conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Galilee Medical Center Department of Internal Medicine A" are "Ulcerative Colitis" (3 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Galilee Medical Center Department of Internal Medicine A" in a lesser frequency.

Most popular intervention types in "Galilee Medical Center Department of Internal Medicine A" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (4 trials), "Placebo" (2 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Galilee Medical Center Department of Internal Medicine A" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Galilee Medical Center Department of Internal Medicine A". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Galilee Medical Center Department of Internal Medicine A, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Galilee Medical Center Department of Internal Medicine A, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".